PFM Health Sciences led a $100m Series C round in Caresyntax.

PFM Health Sciences led a $100m Series C round in Caresyntax, with participation from Optum Ventures, Intel Capital, Lauxera Capital Partners, Vesalius Biocapital, Arno Capital, Rezayat Investments, IPF Partners, the Relyens Group, and Surgical.AI. "Operating rooms need to perform as effectively and efficiently as possible, and this is especially true now to make up for the surgical backlog driven by the pandemic. With better technology to safely automate surgical pathways while generating decision-grade real-world evidence, we will improve health care decision-making, mitigate surgical risks, and advance high-value medical technology," Dennis Kogan, Caresyntax Founder and CEO.